You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant chemoradiation therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

Recruiting
  • Neoadjuvant Chemoradiation Therapy
  • +3 more
  • xintilimab injection
  • Control
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery in Changhai Hospital
Aug 5, 2022

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Houston (Aerobic Exercise, Dietary Intervention, Nutritional

Withdrawn
  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Aerobic Exercise
  • +5 more
  • (no location specified)
Oct 26, 2022

Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

Recruiting
  • Locally Advanced Rectal Cancer
  • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
  • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 25, 2023

Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Neoadjuvant therapy
  • +4 more
  • Foshan, Guangdong, China
  • +2 more
Oct 25, 2022

Rectal Cancer Trial in Alexandria (radiation, drug, procedure)

Completed
  • Rectal Cancer
  • Radiotherapy
  • +2 more
  • Alexandria, Egypt
    Ahmed Samir Ashoor
Mar 7, 2022

Stage III NSCLC Trial in Guangzhou (Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy)

Recruiting
  • Stage III Non-small Cell Lung Cancer
  • Neoadjuvant chemo-immunotherapy
  • +5 more
  • Guangzhou, China
    Sun Yat-sen University
Jul 19, 2022

Glioblastoma, Surgery, High Grade Glioma Trial in Danville, Wilkes-Barre (radiation, drug, procedure)

Recruiting
  • Glioblastoma
  • +2 more
  • Neoadjuvant chemoradiation
  • +2 more
  • Danville, Pennsylvania
  • +1 more
Jan 24, 2022

Cervical Cancer Trial in Chengdu (NACT, CCRT, Brachytherapy)

Not yet recruiting
  • Cervical Cancer
  • Chengdu, Sichuan, China
    Sicchuan cancer hospital
Dec 28, 2021

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX Trial in Kaunas (Radiotherapy 50 Gy, Fluorouracil/folic acid,

Recruiting
  • Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
  • Radiotherapy 50 Gy
  • +2 more
  • Kaunas, Lithuania
    Rita Ambraziene
May 12, 2022

Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma

Recruiting
  • Cholangiocarcinoma
  • Observation data collection study.
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 28, 2022

Pancreatic Cancer Trial in Milwaukee (First-line Chemotherapy, Second-line Chemotherapy, Chemoradiation)

Recruiting
  • Pancreatic Cancer
  • First-line Chemotherapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jul 29, 2022

Locally Advanced Rectal Cancer Trial (Radiation therapy, chemo and immune checkpoint inhibitor)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Radiation therapy, chemotherapy and immune checkpoint inhibitor
  • (no location specified)
Mar 28, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 25, 2022

Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)

Withdrawn
  • Rectal Adenocarcinoma
  • Chemoradiation
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021

Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2023

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Rectal Cancer Stage III Trial in Hangzhou (Neoadjuvant chemoradiotherapy based on irinotecan)

Recruiting
  • Rectal Cancer Stage III
  • Neoadjuvant chemoradiotherapy based on irinotecan
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Dec 7, 2021

A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL

Completed
  • Esophageal Cancer
  • Chemotherapy
  • +4 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 23, 2021

Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022

Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)

Not yet recruiting
  • Locally Advanced Vulvar Carcinoma
  • Squamous Cell Carcinoma of the Vulva
  • Paclitaxel and Carboplatin
  • Chemoradiation
  • (no location specified)
Jun 6, 2023

Oncology Trial in Nijmegen (combined aerobic exercise + resistance exercise intervention (AE + RE), Aerobic exercise prior to

Recruiting
  • Oncology
  • combined aerobic exercise + resistance exercise intervention (AE + RE)
  • Aerobic exercise prior to daily radiotherapy sessions (ExPR)
  • Nijmegen, Gelderland, Netherlands
    Radboud Institute for Health Science
Jan 8, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Tumor, Rectum Trial (Total mesorectal excision before 56 days (4-8 weeks), Total mesorectal excision after 56 days (8-12 weeks))

Completed
Has Results
  • Neoplasm, Rectum
  • Total mesorectal excision before 56 days (4-8 weeks)
  • Total mesorectal excision after 56 days (8-12 weeks)
  • (no location specified)
Mar 22, 2022

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021